FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Korean Drugmaker Draws FDA Warning for Validation, Stability Issues March 2, 2018 HHS Office of Inspector General Calls for More Biosimilar Coverage in Medicare Part D April 5, 2022 Drugmakers Saw Robust ROI and Lower Development Costs in 2021, Says Analysis January 12, 2022